NeuroPace Announces FDA Approval of ECoG Assistant™, Advancing AI-Driven Epilepsy Care

Go back to NeuroPace Announces FDA Approval of ECoG Assistant™, Advancing AI-Driven Epilepsy Care
(NASDAQ: NPCE) Delayed: 14.98 +0.24 (1.63%)
Previous Close $14.74    52 Week High
Open $14.75    52 Week Low
Day High $15.56    P/E N/A 
Day Low $14.68    EPS
Volume 52,287